Disclosures for "Predictive Value of BAFF in Secondary Autoimmunity and Immunodeficiency in Multiple Sclerosis Patients on B-cell Depletion Therapies"
-
Dr. Alexeeva has nothing to disclose.
-
Dr. Chumakova has nothing to disclose.
-
Dr. Thai has nothing to disclose.
-
Dr. Demetriou has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Demetriou has stock in GlyTR Therapeutics. Dr. Demetriou has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Sy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Sy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octave Bioscience. Dr. Sy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Sy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Sy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Sy has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Sy has received intellectual property interests from a discovery or technology relating to health care.